Nature Communications (Mar 2023)

A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression

  • You Li,
  • Zhiqiang Li,
  • Ruiling Chen,
  • Min Lian,
  • Hanxiao Wang,
  • Yiran Wei,
  • Zhengrui You,
  • Jun Zhang,
  • Bo Li,
  • Yikang Li,
  • Bingyuan Huang,
  • Yong Chen,
  • Qiaoyan Liu,
  • Zhuwan Lyu,
  • Xueying Liang,
  • Qi Miao,
  • Xiao Xiao,
  • Qixia Wang,
  • Jingyuan Fang,
  • YongYong Shi,
  • Xiangdong Liu,
  • Michael F. Seldin,
  • M. Eric Gershwin,
  • Ruqi Tang,
  • Xiong Ma

DOI
https://doi.org/10.1038/s41467-023-37213-5
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 14

Abstract

Read online

Primary biliary cholangitis is a rare, chronic immune-mediated liver disease triggered by environmental exposures in genetically susceptible individuals. Here, the authors investigate the functional mechanism underlying the association of 19p13.3 variants with primary biliary cholangitis.